Phase I Study to Evaluate Safety, Tolerability, Anti-Tumour Activity and PK Profiles of Foxy-5 in Metastatic Breast, Colorectal or Prostate Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2015 by WntResearch AB
Sponsor:
Information provided by (Responsible Party):
WntResearch AB
ClinicalTrials.gov Identifier:
NCT02020291
First received: December 11, 2013
Last updated: February 4, 2015
Last verified: February 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2015
  Estimated Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)